Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of photodynamic therapy with lutetium texaphyrin in
treating patients who have cervical intraepithelial neoplasia. Photodynamic therapy uses
light and drugs such as lutetium texaphyrin that make abnormal cells more sensitive to light
and may kill abnormal cells in the cervix and prevent the development of cervical cancer